These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32274652)

  • 41. Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.
    Ng T; Teo SM; Yeo HL; Shwe M; Gan YX; Cheung YT; Foo KM; Cham MT; Lee JA; Tan YP; Fan G; Yong WS; Preetha M; Loh WJ; Koo SL; Jain A; Lee GE; Wong M; Dent R; Yap YS; Ng R; Khor CC; Ho HK; Chan A
    Neuro Oncol; 2016 Feb; 18(2):244-51. PubMed ID: 26289590
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study.
    Hermelink K; Henschel V; Untch M; Bauerfeind I; Lux MP; Munzel K
    Cancer; 2008 Nov; 113(9):2431-9. PubMed ID: 18823033
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of compensatory cognitive training intervention for breast cancer patients undergoing chemotherapy: a pilot study.
    Park JH; Jung YS; Kim KS; Bae SH
    Support Care Cancer; 2017 Jun; 25(6):1887-1896. PubMed ID: 28132089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients.
    Schagen SB; Muller MJ; Boogerd W; Rosenbrand RM; van Rhijn D; Rodenhuis S; van Dam FS
    Ann Oncol; 2002 Sep; 13(9):1387-97. PubMed ID: 12196364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients.
    Jansen CE; Cooper BA; Dodd MJ; Miaskowski CA
    Support Care Cancer; 2011 Oct; 19(10):1647-56. PubMed ID: 20820813
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Cognitive function in breast cancer patients on chemotherapy: a longitudinal study].
    Chen X; Li J; Zhu C; Li D; Zhang J; Wang K
    Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(1):27-30. PubMed ID: 24721302
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Longitudinal Changes in Cognitive Function in a Nationwide Cohort Study of Patients With Lymphoma Treated With Chemotherapy.
    Janelsins MC; Mohamed M; Peppone LJ; Magnuson A; Belcher EK; Melnik M; Dakhil S; Geer J; Kamen C; Minasian L; Reagan PM; Mohile SG; Morrow GR; Ahles TA; Heckler CE
    J Natl Cancer Inst; 2022 Jan; 114(1):47-59. PubMed ID: 34255086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of physical exercise on cognitive function and brain measures after chemotherapy in patients with breast cancer (PAM study): protocol of a randomised controlled trial.
    Witlox L; Schagen SB; de Ruiter MB; Geerlings MI; Peeters PHM; Koevoets EW; van der Wall E; Stuiver M; Sonke G; Velthuis MJ; Palen JAMV; Jobsen JJ; May AM; Monninkhof EM
    BMJ Open; 2019 Jun; 9(6):e028117. PubMed ID: 31227537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Persistent cognitive changes in breast cancer patients 1 year following completion of chemotherapy.
    Collins B; Mackenzie J; Tasca GA; Scherling C; Smith A
    J Int Neuropsychol Soc; 2014 Apr; 20(4):370-9. PubMed ID: 24229809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study.
    Schilder CM; Seynaeve C; Linn SC; Boogerd W; Beex LV; Gundy CM; Nortier JW; van de Velde CJ; van Dam FS; Schagen SB
    Psychooncology; 2012 May; 21(5):479-87. PubMed ID: 21351188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment.
    Collins B; Mackenzie J; Stewart A; Bielajew C; Verma S
    Psychooncology; 2009 Feb; 18(2):134-43. PubMed ID: 18551510
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.
    Schagen SB; van Dam FS; Muller MJ; Boogerd W; Lindeboom J; Bruning PF
    Cancer; 1999 Feb; 85(3):640-50. PubMed ID: 10091737
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chemotherapy-associated cognitive impairments in Korean cancer patients: Risk factors and functional outcome.
    Kim HJ; Barsevick AM; Chan A; Chae JW
    Psychooncology; 2018 Aug; 27(8):1995-2001. PubMed ID: 29744963
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy.
    Ferguson RJ; McDonald BC; Saykin AJ; Ahles TA
    J Clin Oncol; 2007 Sep; 25(25):3866-70. PubMed ID: 17761972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cognitive dysfunction and chemotherapy: neuropsychological findings in perspective.
    Schagen SB; Muller MJ; Boogerd W; Van Dam FS
    Clin Breast Cancer; 2002 Dec; 3 Suppl 3():S100-8. PubMed ID: 12533270
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How to Identify and Manage Cognitive Dysfunction After Breast Cancer Treatment.
    Lange M; Joly F
    J Oncol Pract; 2017 Dec; 13(12):784-790. PubMed ID: 29232539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Language impairment among patients with different types of cancer. Comparison with healthy adults.
    Megari K
    Breast Cancer Res Treat; 2020 Dec; 184(3):779-782. PubMed ID: 32852707
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessing cognitive dysfunction in breast cancer: what are the tools?
    Freeman JR; Broshek DK
    Clin Breast Cancer; 2002 Dec; 3 Suppl 3():S91-9. PubMed ID: 12533269
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemotherapy and Post-traumatic Stress in the Causation of Cognitive Dysfunction in Breast Cancer Patients.
    Hermelink K; Bühner M; Sckopke P; Neufeld F; Kaste J; Voigt V; Münzel K; Wuerstlein R; Ditsch N; Hellerhoff K; Rjosk-Dendorfer D; Braun M; von Koch FE; Härtl K; Hasmüller S; Bauerfeind I; Debus G; Herschbach P; Mahner S; Harbeck N
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28521364
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuropsychological functioning and quality of life during the first year after completing chemotherapy for breast cancer.
    Reid-Arndt SA; Hsieh C; Perry MC
    Psychooncology; 2010 May; 19(5):535-44. PubMed ID: 19472296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.